966
Views
4
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

pH-sensitive interpenetrating polymer network microspheres of poly(vinyl alcohol) and carboxymethyl cellulose for controlled release of the nonsteroidal anti-inflammatory drug ketorolac tromethamine

&
Pages 817-824 | Received 25 Oct 2014, Accepted 25 Oct 2014, Published online: 24 Jan 2015

Figures & data

Figure 1. Structure of KT.

Figure 1. Structure of KT.

Figure 2. Schematic representation of the synthesis of IPN polymers.

Figure 2. Schematic representation of the synthesis of IPN polymers.

Table I. Formulation codes, results of percentage entrapment efficiency, and yield of the microspheres.

Figure 3. FTIR spectrum of (a) pristine PVA, (b) pristine NaCMC, and (c) KT-loaded NaCMC/PVA microspheres (drug/polymer ratio: 1/8 (w/w), polymer/polymer ratio: 1/1 (w/w)).

Figure 3. FTIR spectrum of (a) pristine PVA, (b) pristine NaCMC, and (c) KT-loaded NaCMC/PVA microspheres (drug/polymer ratio: 1/8 (w/w), polymer/polymer ratio: 1/1 (w/w)).

Figure 4. FTIR spectrum of (a) KT-loaded microspheres (drug/polymer ratio: 1/8 (w/w), polymer/polymer ratio: 1/1 (w/w)), (b) pristine KT, and (c) placebo NaCMC/PVA microspheres (polymer/polymer ratio: 1/1 (w/w)).

Figure 4. FTIR spectrum of (a) KT-loaded microspheres (drug/polymer ratio: 1/8 (w/w), polymer/polymer ratio: 1/1 (w/w)), (b) pristine KT, and (c) placebo NaCMC/PVA microspheres (polymer/polymer ratio: 1/1 (w/w)).

Figure 5. DSC thermograms of (a) pristine KT, (b) KT-loaded NaCMC/PVA microspheres (drug/polymer ratio: 1/8 (w/w), polymer/polymer ratio: 1/1 (w/w)), and (c) placebo NaCMC/PVA microspheres (polymer/polymer ratio: 1/1 (w/w)).

Figure 5. DSC thermograms of (a) pristine KT, (b) KT-loaded NaCMC/PVA microspheres (drug/polymer ratio: 1/8 (w/w), polymer/polymer ratio: 1/1 (w/w)), and (c) placebo NaCMC/PVA microspheres (polymer/polymer ratio: 1/1 (w/w)).
Figure 6. Scanning electron micrographs of KT-loaded IPN microspheres (a) 4000 magnification, and (b) 8000 magnification.
Figure 6. Scanning electron micrographs of KT-loaded IPN microspheres (a) 4000 magnification, and (b) 8000 magnification.

Figure 7. X-RD pattern of (a) KT-loaded microspheres, and (b) placebo microspheres.

Figure 7. X-RD pattern of (a) KT-loaded microspheres, and (b) placebo microspheres.

Figure 8. Effect of the NaCMC/PVA ratio on KT release (*):1/1, (x):1/2, (▲):1/4, (■):1/6, (♦):1/8, (drug/polymer ratio:1/8, concentration of GA:0.66 M, exposure time to GA:30 min.).

Figure 8. Effect of the NaCMC/PVA ratio on KT release (*):1/1, (x):1/2, (▲):1/4, (■):1/6, (♦):1/8, (drug/polymer ratio:1/8, concentration of GA:0.66 M, exposure time to GA:30 min.).

Figure 9. Effect of the drug/polymer ratio on KT release (*):1/8, (x):1/6, (▲):1/4, (■):1/2, (♦):1/1, (NaCMC/PVA ratio:1/1, concentration of GA:0.66 M, exposure time to GA:30 min.).

Figure 9. Effect of the drug/polymer ratio on KT release (*):1/8, (x):1/6, (▲):1/4, (■):1/2, (♦):1/1, (NaCMC/PVA ratio:1/1, concentration of GA:0.66 M, exposure time to GA:30 min.).

Figure 10. Effect of the exposure time on KT release (♦): 30 min., (■): 45 min. (NaCMC/PVA ratio: 1/1, drug/polymer ratio:1/8, concentration of GA:0.66 M).

Figure 10. Effect of the exposure time on KT release (♦): 30 min., (■): 45 min. (NaCMC/PVA ratio: 1/1, drug/polymer ratio:1/8, concentration of GA:0.66 M).

Table II. Results of swelling study of empty IPN microspheres.

Table III. Results of k, n and r calculated with equation (3).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.